Close Menu

NEW YORK – Ortho Clinical Diagnostics announced on Tuesday that the US Food and Drug Administration has issued Emergency Use Authorization for the company's Vitros SARS-CoV-2 Antigen test for detection of the coronavirus.

According to the Raritan, New Jersey-based firm, the test is the first high-volume COVID-19 antigen test to receive EUA. It previously was CE marked in November.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.